NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variants.

Hum Vaccin Immunother · 2026 · PMC13154980 · PMID 42083894

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendp = .052so close (0.05 < p ≤ 0.1)

On multiple regression, baseline anti-S titers were significantly higher among those with prior COVID-19 infection ( p < .0001), whereas current smokers showed a trend toward lower titers (p = .052) (Supplementary Table 2).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.